Psychedelic experience

Jump to navigation Jump to search
Psychedelic experience

WikiDoc Resources for Psychedelic experience

Articles

Most recent articles on Psychedelic experience

Most cited articles on Psychedelic experience

Review articles on Psychedelic experience

Articles on Psychedelic experience in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Psychedelic experience

Images of Psychedelic experience

Photos of Psychedelic experience

Podcasts & MP3s on Psychedelic experience

Videos on Psychedelic experience

Evidence Based Medicine

Cochrane Collaboration on Psychedelic experience

Bandolier on Psychedelic experience

TRIP on Psychedelic experience

Clinical Trials

Ongoing Trials on Psychedelic experience at Clinical Trials.gov

Trial results on Psychedelic experience

Clinical Trials on Psychedelic experience at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Psychedelic experience

NICE Guidance on Psychedelic experience

NHS PRODIGY Guidance

FDA on Psychedelic experience

CDC on Psychedelic experience

Books

Books on Psychedelic experience

News

Psychedelic experience in the news

Be alerted to news on Psychedelic experience

News trends on Psychedelic experience

Commentary

Blogs on Psychedelic experience

Definitions

Definitions of Psychedelic experience

Patient Resources / Community

Patient resources on Psychedelic experience

Discussion groups on Psychedelic experience

Patient Handouts on Psychedelic experience

Directions to Hospitals Treating Psychedelic experience

Risk calculators and risk factors for Psychedelic experience

Healthcare Provider Resources

Symptoms of Psychedelic experience

Causes & Risk Factors for Psychedelic experience

Diagnostic studies for Psychedelic experience

Treatment of Psychedelic experience

Continuing Medical Education (CME)

CME Programs on Psychedelic experience

International

Psychedelic experience en Espanol

Psychedelic experience en Francais

Business

Psychedelic experience in the Marketplace

Patents on Psychedelic experience

Experimental / Informatics

List of terms related to Psychedelic experience

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

A psychedelic experience, or trip, is characterized by the perception of aspects of one's mind previously unknown, or by the creative exuberance of the mind liberated from its ordinary fetters. Psychedelic states are one of the stations on the spectrum of experiences elicited by sensory deprivation as well as by psychedelic substances. On that same spectrum will be found hallucinations, changes of perception, synesthesia, altered states of awareness, mystical states, and occasionally states resembling psychosis. The word psychedelic comes from a combination of two Greek words: psyche (ψυχή) and delos (δήλος). Literally, it means "mind manifesting".

The psychedelic experience is an intimate experience, but there are many common themes, and ranges from a sense of connectedness to everything in the immediate vicinity, to a sense of oneness with everything in the universe. Potentially, the range of the drug-induced psychedelic experience goes far beyond other drugs, illicit in particular. Simply because "trip drugs", or hallucinogenic drugs have these effects, in contrast to say heroin, and its depressant effects.

Many who undertake such experiences come to see them as an ordeal, and mentally overbearing. For many, such experiences come to be seen as personal re-enactments of the hero's journey. Psychedelic drugs can be used as a means to achieve states of mind in which different perceptions unhindered by everyday mental filters and processes can arise. Hallucinations and the mental, emotional and long term impact of the experience are positive and enduring for many.

There has been research, largely during the 1960s, suggesting that psychedelic drugs may be able to lead to breakthrough experiences during psychotherapy and or have documented pharmaceutical advantages.

The Multidisciplinary Association for Psychedelic Studies or MAPS is a more current organization that studies the effects of psychedelics. They have a number of books and other scientific journals that have documented psychedelic experiences and information.

Levels of psychedelic experience

The Psychedelic Experience FAQ describes five different levels of psychedelic experience:

Level 1

This level produces a mild "high" effect, with some visual enhancement (e.g. brighter colors) and music sounds "wider," or more piercing to the ears. This level can be achieved from a normal dose of cannabis or a very low dose of a classic psychedelic such as psilocybin. Occasionally common prescription drugs like SSRIs and the like can produce mild 'trippy' effects, as well, though they are not normally classified as psychedelic experiences because they are so mild.

Level 2

Bright colors; visuals (e.g. things may appear to move or breathe); some two-dimensional patterns become apparent upon shutting eyes. Confused, cyclic or reminiscent thoughts. Change in short term memory leads to continually distracting thought patterns. While it may become increasingly difficult to follow a single train of thought, at other times one might find themselves lost in deep introspection about one specific idea or problem. The need to see 'normal' reality becomes less, the urge to venture 'beyond the void' becomes more. Level 3 tripping can intersperse with level 2 as long as eyes are shut. This state can be achieved from a high dose of THC or a low dose of psilocybin or LSD.

Level 3

Very obvious visuals, everything looking curved and/or warped, patterns, kaleidoscopes or fractal images seen on walls, landscapes, faces, etc. Closed eye hallucinations become three dimensional. There is some confusing of the senses (synesthesia). Time distortions and "moments of eternity". Movement at times becomes extremely difficult (too much effort required). A normal dose of either psilocybin or LSD can produce this effect.

Level 4

Strong visual effects, e.g. objects morphing into other objects. Dissolving or multiple splitting of the ego (e.g. things start talking, or feeling of contradictory things simultaneously). The loss of sense of self can bring a shift in the sense of reality, often accompanied by a sense of ineffable lucidity. Time becomes very distorted and participants may perceive an activity lasting only minutes to have encompassed hours of their own reality. Out-of-body experiences and ESP-type experiences. A high dose of psilocybin can produce this effect, as can a normal to high dose of LSD.

Level 5

Total loss of visual connection with reality. The senses cease to function in the normal way. Total loss of ego. Feelings of merging with space, other objects or the universe. Feelings of reaching to the beginning or the end of space and time. The loss of reality becomes so extreme that it defies explanation. Dream or movie like states, people have been reported seeing themselves in entirely different settings than their original setting. Earlier levels are relatively easy to describe in terms of measurable changes in perception and thought patterns. The only thing still reported to be working at a recognizable level, is the mind's voice of thought. Much is unknown about what a person actually experiences during this period, because most people actually come back explaining the experience as "unexplainable" or "uncommunicable". This effect can be produced in high doses of LSD, DXM and extremely high doses of psilocybin or with extremely high doses of the strongest extracts of salvia divinorum. DMT is known to send people to level 5 with a common smoked dose, making it one of the most powerful psychedelics known to man.

Psychedelic drugs

See also

References

  • Stafford, Peter. (2003). Psychedlics. Ronin Publishing, Oakland, California. ISBN 0-914171-18-6.

External links

Template:Skin and subcutaneous tissue symptoms and signs Template:Nervous and musculoskeletal system symptoms and signs Template:Urinary system symptoms and signs Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:Speech and voice symptoms and signs Template:General symptoms and signs

Template:SIB



de:Trip


Template:WikiDoc Sources